The latest development of PROTAC worldwide
Focus on the most cutting-edge research results in the field of protein degradation and catch the latest developments in the PROTAC market? It's all in the five-minute "Today's PROTAC Headlines" series of tweets from Minox's ReThinking PROTAC platform.
Recently, Kymera Therapeutics Publishes Recent Patent for SMARCA degrader (WO 2022/125804 A1), Ram Sabnis (Smith, Gambrell & Russell LLP, "The patent was refined and briefly analyzed in ACS Medicinal Chemistry."
1, represents the molecule
2. Targets and indications
Target: Switch/Sucrose Non-Fermentable (SWI/SNF)-Related, Matrix-Associated, Actin-Dependent Regulator of Chromatin, Subfamily A (SMARCA), including SMARCA2, SMARCA4, PB1, etc.
◆ Indications: Cancer
3. Synthetic pathways
4. Biological activity
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-08-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Can PROTAC Grab a slice of the $50 billion market for self-medicated drugs?
-
Treatment Guide' for Alopecia Starman
-
Blue from the Rainforest: EFSA Greenlights Natural “Jagua Blue” as Safe Food Colorant
-
From Eggshell to Elixir: EFSA Declares Egg Membrane Collagen Peptides Safe for Adult Supplements
-
Probiotic Promise, Safety Snag: EFSA Gives Mixed Verdict on Multi-Strain Dog Feed Additive
-
From Ancient Volcanoes to Modern Feed Mills: EFSA Validates Volcanic Zeolite as Safe and Effective Feed Additive
-
Spice Up the Coop: EFSA Reaffirms Safety of Botanical Blend for Broiler Feed—With a Warning for Handlers
-
Bridgestone Reports Q3 Growth Amid Challenging North American Market
-
Trinseo Faces Pressure in Resin Markets but Sees Growth in Recycled Products
-
Sika Undertakes Structural Adjustments Amid Weak Markets
Recommend Reading
-
EU Officially Approves Rapeseed Oil as a Low-Risk Active Substance Until 2040
-
EFSA Unable to Confirm Safety of Fusarium flavolapis Fungal Protein as a Novel Food
-
EFSA Confirms Safety of β-Amylase Produced from Barley for Food Manufacturing Use
-
Hormuz Is Reopening, But Chemical Logistics May Take Months to Recover
-
EFSA Evaluates Extended Use of Pasteurised Akkermansia muciniphila as a Novel Food
-
Expectations of Tightening Supply Dominate the Recovery in Formic Acid Prices
-
Calcium Acetate: Medical and Industrial Applications
-
This week, the price of polyester bottle chips fluctuated and rose
-
Bullish Support Pushes Up January Adipic Acid Prices in China
-
This Week, the Transaction Focus of China's Propylene Oxide Market Rises (11.10-11.14)